A three-year, non-interventional, prospective, multicenter study to evaluate the long-term effectiveness of lanadelumab in real-world clinical practice (ENABLE)
Show More
ENABLE (SHP643-402)
Exco InTouch (an ERT Company)
Free
10+
downloads
About ENABLE (SHP643-402)
ENABLE (SHP643-402) Screenshots
